Caris Launches ChromoSeq for Myeloid Cancer Profiling
IRVING, Texas, USA — April 1, 2026 Caris Life Sciences® has announced the launch of Caris ChromoSeq™, the world’s...
AI
Advertisement
Bio-Techne and Nucleai Advance AI Spatial Biology to Unlock Melanoma Biomarkers
MINNEAPOLIS, USA, and TEL AVIV, Israel, November 4, 2025 — Bio-Techne Corporation (NASDAQ: TECH) and Nucleai, an AI-driven precision-medicine...
Swiss Rockets Partners with Squirro to Transform AI in Biotech
Basel, Switzerland – October 23, 2025: Swiss Rockets AG has announced a strategic partnership with Squirro AG aimed at...
Boston Scientific to Acquire Nalu Medical for Pain Therapy Expansion
Marlborough, MA – October 17, 2025 – Boston Scientific Corporation announced that it has entered into a definitive agreement...
FDA Fast Tracks Enterome’s OncoMimics™ Cancer Immunotherapy EO2463
Paris, France – October 16, 2025 – The U.S. Food and Drug Administration (FDA) has granted Fast Track designation...
Advertisement
